John F. Milligan

Chief Financial Officer, Gilead Sciences.

Companies

Kailera Therapeutics, Inc.Board member Apr 16, 2026 to now¹
4D Molecular Therapeutics, Inc.Board member Dec 10, 2020 to now²
Pacific BiosciencesBoard member Jul 18, 2013 to now³
Gilead SciencesChief executive officer Apr 5, 2016 to Nov 29, 2018⁴
Gilead SciencesBoard member Feb 3, 2016 to Nov 29, 2018⁵
Gilead SciencesPresident May 9, 2008 to Nov 29, 2018⁶
Gilead SciencesChief operating officer May 10, 2007 to Mar 3, 2016⁷
Gilead SciencesChief financial officer Jan 27, 2006 to Mar 19, 2008⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pacific Biosciences PACB132,821 shares⁹$237.1K at $1.78Jun 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 18, 2024Granted 22,821 shares of Pacific Biosciences⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKailera Therapeutics, Inc., Board member
2
SEC EDGAR4D Molecular Therapeutics, Inc., Board member
3
SEC EDGARPacific Biosciences, Board member
4
SEC EDGARGilead Sciences, Chief executive officer
5
SEC EDGARGilead Sciences, Board member
6
SEC EDGARGilead Sciences, President
7
SEC EDGARGilead Sciences, Chief operating officer
8
SEC EDGARGilead Sciences, Chief financial officer
9
SEC EDGARPacific Biosciences shares after the filing of Jun 18, 2024